A detailed history of Ifp Advisors, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ifp Advisors, Inc holds 12,010 shares of ABT stock, worth $1.37 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,010
Previous 10,361 15.92%
Holding current value
$1.37 Million
Previous $1.18 Million 5.95%
% of portfolio
0.05%
Previous 0.05%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$100.73 - $112.44 $166,103 - $185,413
1,649 Added 15.92%
12,010 $1.25 Million
Q1 2024

Jul 30, 2024

BUY
$109.52 - $120.96 $38,770 - $42,819
354 Added 3.54%
10,361 $1.18 Million
Q4 2023

Jan 09, 2024

SELL
$90.19 - $110.4 $579,019 - $708,768
-6,420 Reduced 39.08%
10,007 $1.1 Million
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $320,694 - $384,779
3,357 Added 25.68%
16,427 $1.59 Million
Q2 2023

Aug 04, 2023

SELL
$100.78 - $112.29 $1.31 Million - $1.46 Million
-13,005 Reduced 49.88%
13,070 $1.42 Million
Q1 2023

Apr 18, 2023

SELL
$96.86 - $114.01 $934,408 - $1.1 Million
-9,647 Reduced 27.01%
26,075 $2.64 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $40,495 - $47,507
426 Added 1.21%
35,722 $1.66 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $605,717 - $701,307
6,260 Added 21.56%
35,296 $1.74 Million
Q2 2022

Sep 06, 2022

BUY
$102.07 - $123.37 $2.95 Million - $3.56 Million
28,895 Added 20492.91%
29,036 $1.46 Million
Q2 2022

Aug 12, 2022

SELL
$102.07 - $123.37 $2.95 Million - $3.56 Million
-28,895 Reduced 99.51%
141 $6,000
Q1 2022

Sep 06, 2022

BUY
$114.02 - $139.04 $924,246 - $1.13 Million
8,106 Added 38.73%
29,036 $3.44 Million
Q1 2022

Aug 08, 2022

BUY
$114.02 - $139.04 $297,136 - $362,338
2,606 Added 14.22%
20,930 $2.48 Million
Q4 2021

Jan 12, 2022

BUY
$115.53 - $141.46 $1,501 - $1,838
13 Added 0.07%
18,324 $2.58 Million
Q3 2021

Oct 06, 2021

BUY
$116.66 - $129.06 $348,813 - $385,889
2,990 Added 19.52%
18,311 $2.16 Million
Q2 2021

Jul 13, 2021

SELL
$105.79 - $124.53 $291,345 - $342,955
-2,754 Reduced 15.24%
15,321 $1.78 Million
Q1 2021

Apr 30, 2021

SELL
$108.84 - $128.23 $230,196 - $271,206
-2,115 Reduced 10.48%
18,075 $2.17 Million
Q4 2020

Jan 25, 2021

SELL
$105.0 - $114.42 $137,445 - $149,775
-1,309 Reduced 6.09%
20,190 $2.21 Million
Q3 2020

Oct 29, 2020

SELL
$91.64 - $111.29 $578,523 - $702,573
-6,313 Reduced 22.7%
21,499 $2.33 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $831,550 - $1.06 Million
10,860 Added 64.06%
27,812 $2.47 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $248,892 - $363,949
3,962 Added 30.5%
16,952 $1.29 Million
Q4 2019

Jan 17, 2020

SELL
$78.51 - $87.4 $293,862 - $327,138
-3,743 Reduced 22.37%
12,990 $1.14 Million
Q3 2019

Nov 07, 2019

BUY
$81.84 - $88.74 $484,656 - $525,518
5,922 Added 54.78%
16,733 $1.37 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $2.06 Million - $2.49 Million
-31,137 Reduced 74.23%
10,811 $864,000
Q4 2018

Jan 23, 2019

SELL
$65.56 - $74.27 $403,456 - $457,057
-6,154 Reduced 12.79%
41,948 $3.03 Million
Q3 2018

Oct 25, 2018

BUY
$60.81 - $73.36 $105,383 - $127,132
1,733 Added 3.74%
48,102 $0
Q2 2018

Aug 07, 2018

SELL
$57.57 - $63.54 $345 - $381
-6 Reduced 0.01%
46,369 $0
Q1 2018

Jun 03, 2019

BUY
$56.27 - $63.62 $32,130 - $36,327
571 Added 1.25%
46,375 $2.65 Million
Q1 2018

May 09, 2018

SELL
$56.27 - $63.62 $32,130 - $36,327
-571 Reduced 1.23%
45,804 $0
Q4 2017

Jan 24, 2018

SELL
$53.68 - $57.47 $1.72 Million - $1.84 Million
-31,987 Reduced 40.82%
46,375 $0
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $107,462 - $119,939
2,236 Added 2.94%
78,362 $4.18 Million
Q2 2017

Jun 03, 2019

SELL
N/A
-1,889 Reduced 2.42%
76,126 $3.7 Million
Q1 2017

Jun 03, 2019

BUY
N/A
8,581 Added 12.36%
78,015 $3.47 Million
Q4 2016

Jun 03, 2019

SELL
N/A
-1,407 Reduced 1.99%
69,434 $2.67 Million
Q2 2016

Jun 03, 2019

BUY
N/A
60,030 Added 555.27%
70,841 $2.79 Million
Q1 2016

Jun 03, 2019

BUY
N/A
10,811
10,811 $864,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.